Abstract
We investigated in vivo neurochemical markers reflective of neuronal health and glial activation to determine if these could yield clues regarding the reduced fractional anisotropy (FA) of white matter and accelerated decline of FA with age in schizophrenia. Participants with schizophrenia and healthy controls completed diffusion tensor imaging to assess FA and proton magnetic resonance spectroscopy to assess neurochemical metabolites in the same frontal region. Frontal FA was significantly lower in the schizophrenia and declined more rapidly with age compared with the healthy control group. In both groups, N-acetylaspartate (NAA), a putative marker of neuronal integrity, and glutamate declined with age, and this decline was stronger in patients. Myo-inositol, a marker of glial cells, was negatively related to FA in both groups. The relationship between FA and age remained significant in schizophrenia even when controlling for all metabolites. The relationships of FA, NAA and myo-inositol to age appear to be independent of one another. The relationship between FA and myo-inositol was independently present in both patients and controls, even after controlling for age, indicating a potential general effect of neuroinflammation on white matter microstructure. Further studies are warranted to determine the underlying mechanism driving the accelerated FA decline with age in schizophrenia.
Highlights
Growing evidence suggests white matter dysfunction is part of the pathophysiology in schizophrenia.[1,2,3] Compromised white matter function likely contributes to the synchronization and connectivity abnormalities observed in schizophrenia.[4]
Using proton magnetic resonance spectroscopy (1H-MRS), we previously demonstrated that white matter N-acetylaspartate (NAA) concentrations were capable of explaining age-related Fractional anisotropy (FA) variances in normal controls.[16]
Relationship with age Age was significantly associated with whole-brain average FA, frontal FA and three metabolites, glutamate, myo-inositol and NAA measured in the frontal region of interest (ROI) in the combined sample and independently in normal controls and schizophrenia patients (Table 2 and Figures 2a and d)
Summary
Growing evidence suggests white matter dysfunction is part of the pathophysiology in schizophrenia.[1,2,3] Compromised white matter function likely contributes to the synchronization and connectivity abnormalities observed in schizophrenia.[4].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
